drug delivery

Eastman introduces new excipient to formulate poorly soluble API
Eastman introduces new excipient to formulate poorly soluble API
CP Wire
Eastman
API
BioSustane
drug delivery
excipients
Flag link:
Eastman introduces new excipient to formulate poorly soluble API
Eastman
API
BioSustane
drug delivery
excipients
Flag link:
In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'
In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'
Endpoints
Regeneron
Novartis
Eylea
drug delivery
patents
Lucentis
Flag link:
Georgia Tech spinout bags cash for nucleic acid delivery R&D
Georgia Tech spinout bags cash for nucleic acid delivery R&D
Fierce Pharma
Piezo Therapeutics
drug delivery
nucleic acid delivery
Georgia Tech
R&D
Flag link:
Promising gene therapy delivers treatment directly to brain
Promising gene therapy delivers treatment directly to brain
Stat
gene therapy
brain
drug delivery
PTC Therapeutics
Flag link:
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts
Fierce Pharma
Eli Lilly
Merck
PeptiDreams
peptides
drug delivery
Flag link:
On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access
On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access
BioSpace
vaccines
drug delivery
needle free delivery
Flag link:
Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines
Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines
Fierce Pharma
Zosano Pharma
Emergex
drug delivery
bankruptcy
Flag link:
Eisai cuts the ribbon on $69M injectable drug delivery facility
Eisai cuts the ribbon on $69M injectable drug delivery facility
Fierce Pharma
Eisai
injectables
drug delivery
R&D
Flag link:
Cure Pharmaceutical sells drug delivery patents in $20M deal
Cure Pharmaceutical sells drug delivery patents in $20M deal
Fierce Pharma
Cure Pharmaceutical
drug delivery
patents
intellectual property
Flag link:
Lilly taps Triastek to use 3D printing for gut-targeted drug delivery
Lilly taps Triastek to use 3D printing for gut-targeted drug delivery
Fierce Pharma
Eli Lilly
3D printing
drug delivery
Triastek
Flag link:
Biora, with spin on Xeljanz nearing the clinic, posts data on its targeted gut drug delivery device
Biora, with spin on Xeljanz nearing the clinic, posts data on its targeted gut drug delivery device
Fierce Pharma
Biora
Xeljanz
drug delivery
PGN-600
Progenity
Flag link:
Hovione's drug delivery tech lands eye disease licensing deal
Hovione's drug delivery tech lands eye disease licensing deal
Fierce Pharma
Hovione
drug delivery
Ji Xing Pharmaceuticals
JX08
eye disease
Flag link:
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute
Fierce Pharma
Alkermes
JNJ
Janssen
drug delivery
Nanocrystal
Flag link:
BioNTech Partners with Matinas BioPharma to Develop New Delivery Technology for mRNA Vaccines
BioNTech Partners with Matinas BioPharma to Develop New Delivery Technology for mRNA Vaccines
Xtalks
BioNTech
Matinas
drug delivery
vaccines
MRNA
Flag link:
Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B
Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B
BioSpace
Halozyme Therapeutics
Antares Pharma
M&A
drug delivery
Medtech
Flag link:
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trial
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trial
Fierce Pharma
Genprex
gene therapy
Merck Keytruda
non-small cell lung cancer
drug delivery
Flag link:
Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Roche's Chugai pays Halozyme $25M to access subcutaneous delivery tech
Fierce Biotech
Roche
Chugai
drug delivery
subcutaneous drug delivery
Haolzyme Therapeutics
Enhanze
Flag link:
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact
Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact
Fierce Pharma
Novo Nordisk
drug delivery
bioelectronics
biosensors
MIT
Brigham and Women's
Flag link:
Novo Nordisk extends innovative drug delivery research tie-up with MIT and BWH
Novo Nordisk extends innovative drug delivery research tie-up with MIT and BWH
Biopharma Reporter
Novo Nordisk
R&D
MIT
Brigham and Women's
drug delivery
Flag link:

Pages